Arriving in the arena of obesity therapy, retatrutide represents a different method. Unlike many existing medications, retatrutide works as a dual agonist, simultaneously targeting both GLP peptide-1 (GLP-1) and https://vinnydqhx828743.gynoblog.com/37549836/a-new-retatrutide-a-glp-gip-binding-site-agonist